HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A "null allele" mutation is responsible for erythropoietic protoporphyria in an Israeli patient who underwent liver transplantation: relationships among biochemical, clinical, and genetic parameters.

Abstract
Mutations in the human ferrochelatase gene (FECH) are the primary cause of the inborn disorder erythropoietic protoporphyria (EPP). While the majority of the EPP patients exhibit only photosensitivity, a small percentage of patients (approximately 2%) develop liver complications in addition to the cutaneous symptoms. In this study, the FECH gene of an Israeli EPP patient who suffered from EPP-related liver complications was sequenced. A splicing defect IVS10+1, g-->t, which is known to cause the deletion of exon 10, was identified in the index patient as well as in his symptomatic older sister and his asymptomatic mother. Like the other 12 known FECH mutations associated with liver complications, IVS10+1, g-->t is a "null-allele" mutation. Although the two siblings with overt EPP share an identical genotype with respect to both the mutation on one FECH allele and three intragenic single nucleotide polymorphisms, -251G, IVS1-23T, and IVS3-48C on the other allele, the sister of the index patient has so far shown no signs of liver involvement, suggesting that additional factors might account for the liver disease in EPP.
AuthorsNili Schoenfeld, Rivka Mamet, Elisabeth I Minder, Xiaoye Schneider-Yin
JournalBlood cells, molecules & diseases (Blood Cells Mol Dis) 2003 May-Jun Vol. 30 Issue 3 Pg. 298-301 ISSN: 1079-9796 [Print] United States
PMID12737948 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Ferrochelatase
Topics
  • Adult
  • Alleles
  • Exons
  • Family Health
  • Ferrochelatase (genetics)
  • Humans
  • Israel
  • Liver Transplantation
  • Male
  • Mutation
  • Porphyria, Hepatoerythropoietic (etiology, genetics)
  • RNA Splicing (genetics)
  • Sequence Analysis, DNA
  • Sequence Deletion

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: